Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 27c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.21), $0.27 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $0 versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Green Dot and CommerceOne shareholders approve acquisition deal
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance